The RET fusion gene is a novel oncogene identified recently in NSCLC, and young Asian women, nonsmokers, and patients with lung adenocarcinoma are good candidates for personalized diagnosis and treatment [43]. This evidence concerns the gene RET and lung adenocarcinoma.